“Neovasc Inc. has announced that a first patent covering the company’s innovative Tiara™ transcatheter mitral valve replacement technology has been issued by the US Patent and Trademark Office.”
Research and publish the best content.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
 Your new post is loading...
Scoop.it!
“Neovasc, a medical device company, has obtained the first patent from the US Patent and Trademark Office (USPTO) for its Tiara transcatheter mitral va (Neovasc obtains US patent for Tiara transcatheter mitral valve replacement technology: Neovasc,...”
Scoop.it!
Leading cardiac surgery program and patient advocacy website join forces to raise awareness to heart valve disease. | Virtual Strategy Magazine is an online publication devoted entirely to virtualization technologies.
Scoop.it!
Early surgical repair of severe mitral valve regurgitation from flail leaflets improved long-term outcomes compared with waiting until symptoms or other surgical indications appeared, a registry study showed.
Scoop.it!
A single-centre, observational study, published in Interactive Cardiovascular and Thoracic Surgery, showed that transcatheter aortic valve implantation (TAVI) with a self-expanding valve (CoreValve, Medtronic) was a safe and effective treatment for nine severe aortic stenosis patients who had previously undergone mitral valve surgery.
Scoop.it!
TransCardiac Therapeutics Inc.'s ("TCT" or the "Company") Chief Scientific Officer, Dr. Omar Lattouf, was invited by the organizers of the Transcatheter Cardiovascular Therapeutics conference to present the Company's minimally invasive mitral valve repair device, the TransCardiac MitraFlex.
Scoop.it!
A debate at the 25th annual TCT Conference on the merits of robotic surgery for the treatment of mitral valve disease actually came to more common ground than conflict.
Scoop.it!
Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised an additional $3M in a second closing of its over-subscribed Series A financing, which now totals approximately $11M. Additional Series A investors include BioMedInvest II LP and Edwards LifeSciences (NYSE: EW). Lead investors Wellington Partners and Seventure Partners, added to their investment from the first close, which also included High-Tech Gruenderfonds.
Scoop.it!
TORONTO, Oct. 10, 2013 /PRNewswire/ -- Dynamic US Market For Heart Valve Devices Will See Rapid Expansion Through 2022. Competitors Seeking To Replicate Success of Edwards Lifesciences' SAPIEN Valve, According to Millennium Research Group.
Scoop.it!
In March, an advisory panel voted 5-3 that the benefits of the MitraClip outweigh the risks. But the panel felt Abbott did not prove MitraClip offered a better benefit-risk profile than surgery.
Scoop.it!
Pushing the envelope on conventional surgical procedures in marginal donor hearts (both before and after transplantation) may not only improve the patient’s functional status and reduce the need for retransplantation, but it may ultimately alleviate the chronic shortage of donor hearts.
Scoop.it!
The mitral valve prolapse doesn't create too much trouble typically. Not often, there may be a leakage through which blood may go out in wrong way in floppy valve. This is the most common illness that approximately five to ten percent of total population in the world is going through this.
Scoop.it!
“ The NeoChord DS1000 (A) has the following features: A tip with expandable jaws to grasp the leaflet and 4 fiber-optic channels (B) each of which correspon”
Scoop.it!
“First Gene Detected For Most Common Form Of Mitral Valve Prolapse RedOrbit Research on the DNA of a large multi-generational family has provided a genetic clue that enabled scientists to pinpoint a gene that plays a role in mitral valve prolapse...”
Scoop.it!
“ LOS ANGELES -- Percutaneous mitral valve replacement may be on the horizon, first-in-man results suggest. [...] CardiAQ's percutaneous mitral valve is a self-positioning, self-anchoring bioprosthesis designed to address functional mitral regurgitation. Many other similar devices are in the works as well, but mitral valve replacement has proven slower to develop than aortic valve replacement. One of the challenges is the large size of the mitral valve compared with the aortic valve, requiring a larger system for delivery.
Scoop.it!
“ Get an affordable cost for heart valve replacement surgery package in India. Contact PlacidWay & get the best cardiac surgeons at Manipal Hospital.”
Scoop.it!
“Saint Joseph installs MitraClip as alternative to open-heart surgeryThe Lane ReportThis new treatment expands the options for selected patients with MR, especially those who are not candidates for invasive open-heart surgery.”
Scoop.it!
“FDA device approval: Abbott gets a nod for less invasive mitral valve repair ...MedCity NewsAbbott Labs (ABT) announced it received FDA approval for MitraClip, a less-invasive mitral valve repair technology.”
Scoop.it!
We’ve been covering Abbott‘s MitraClip mitral valve repair system since 2004, when it was still a product of Evalve Inc. of Redwood City, CA.
Scoop.it!
“Mitral Valve Repair: Who is a Patient Candidate for a Non-Ablative Fully Non-Invasive Procedure? Authors and Writers: Justin D Pearlman, MD, PhD, FACC and Article Curator: Aviva Lev-Ari, PhD, RN Th...”
Scoop.it!
“Aortic Valve Replacement That Doesn't Require Open Heart SurgeryScience Daily (press release)... Valve Replacement That Doesn't Require Open Heart Surgery. Nov.”
Scoop.it!
“Who is interested to watch this amazing surgery ? http://t.co/QEjyBgdlhD”
|
Curated by Beeyond
BEEYOND is a consulting company in the field of disruptive innovation, accompanying established companies on out-of-the-core growth strategy, from creation of new concepts to product launch. Reach us at: contact@beeyond.fr.
Other Topics
#dot:dot, the community internet
Aidants
Aston-Martin
Augmented & Virtual Reality
Blue Ocean Strategy
Brain Computer Interfaces & connected medical devices
Consumer Digital Health
Covid-19, SARS-Cov-2, vaccines, Remdesivir, Chloroquine...and all that Jazz
Critical Limb-Threatening Ischemia (CLTI)
Daily realities of diabetic patients
Fashion & technology
Glioblastoma
Healthcare: reloaded...
High level trending in...
In-Vitro Diagnostic
Innovating to what's next...
Instrumental cosmetics
Interventional Cardiology
Intra-Dermal drug delivery: Opportunities and Challenges?
Metabolic Activation Therapy
Multiple sclerosis
Neurovascular Intervention
Nudges
Peritoneal dialysis
SPV
Tailored Expertise Sourcing & Market Intelligence in Global Consulting
The future of e-cigarette
The Revolution Of The Car Industry
Track & Trace
Transcatheter Treatment of Mitral Regurgitation
|
